Washington, 24 Oct 2024: Merck has acquired Modifi Biosciences, a biotechnology company focused on direct DNA modification-enabled cancer therapeutics, for up to $1.3bn

 

As per the terms of the agreement, Merck has acquired all outstanding shares of Modifi B......
View Details

Related News

• Critical medicines for cancer, diabetes set to get expensive as govt clears price hike, say sources (27-03-2025)

---

• DGFT proposes mandatory GST E-Invoices for pharma export benefits (27-03-2025)

---

• US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome (27-03-2025)

---

• FDA approves GSK’s 'Blujepa' for uncomplicated UTIs (27-03-2025)

---

• Bengal drug control publishes helpline to report fake medicines (27-03-2025)

---

• Misleading ads: SC asks states UTs to set up grievance redressal mechanism (26-03-2025)

---

• WHO partners with regulators, experts to strengthen safety and access of medical devices (26-03-2025)

---

• PCI warns of tough action against inspectors who don't follow its guidelines during inspection (26-03-2025)

---

• Seizure of fake Human Albumin Vials rings alarm bells (26-03-2025)

---

• Pharmacy owner, three others held for illegal sale of intoxication drug (26-03-2025)

---